Quantification and stability of salbutamol in human urine

Journal of Separation Science

Volumn 27, Issue 1-2, 2004, Pages 110-114

  Forsdahl, Guro ^a   Gmeiner, Günter ^a  

^a ARC SEIBERSDORF RESEARCH GMBH   (Austria)

Author keywords

Doping; Gas chromatography mass spectrometry; Salbutamol; Solid phase extraction; Urine

Indexed keywords

AROMATIC COMPOUNDS; DERIVATIVES; EXTRACTION; GAS CHROMATOGRAPHY; MASS SPECTROMETRY; SAMPLING; STABILITY;

DERIVATIZATION; SALBUTAMOL;

CHEMICAL ANALYSIS;

SALBUTAMOL; TERBUTALINE; TRIFLUOROACETAMIDE DERIVATIVE;

ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; DERIVATIZATION; DOPING; DRUG EXCRETION; DRUG ISOLATION; DRUG METABOLISM; DRUG STABILITY; DRUG STRUCTURE; DRUG URINE LEVEL; ESCHERICHIA COLI; FEMALE; GAS CHROMATOGRAPHY; HELIX POMATIA; HUMAN; HUMAN EXPERIMENT; MALE; MASS SPECTROMETRY; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; SOLID PHASE EXTRACTION; URINALYSIS; VALIDATION PROCESS; VOLUNTEER;

ALBUTEROL; DOPING IN SPORTS; DRUG STABILITY; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; TRIFLUOROACETIC ACID; TRIMETHYLSILYL COMPOUNDS;

ESCHERICHIA COLI; HELIX POMATIA;

EID: 0442309864     PISSN: 16159306     EISSN: None     Source Type: Journal    
DOI: 10.1002/jssc.200301655     Document Type: Article

References (20)

1. R. Bergés, J. Segura, R. Ventura, K.D. Fitch, A.R. Morton, M. Farré, M. Mas, X. De La Torre, Clin. Chem. 2000, 46, 1365-1375.
2. Olymphic Movement Antidoping-Code Appendix A, 2003, IOC Medical Commission, Lausanne, Switzerland.
3. M. Verroken, Balliére's Clin. Endocrinol. Metabol. 2000, 51, 1-23.
4. F. Jorge Dos Ramos, J. Chromatogr. A 2000, 880, 69-83.
5. R. Bergés, J. Segura, R. Ventura, X. De La Torre, M. Mas, M. Farre, K.D. Fitch, A.R. Morton, M. Ueki, in: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (Eds.), Recent Advances in Doping Analysis (6), Proceedings of the 16th Cologne Workshop on Dope Analysis, Verlag Sport und Buch Strauss, Cologne 1998, pp. 405-419.
6. N. Halatcheva, E. Daneva, in: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (Eds.), Recent Advances in Doping Analysis (8), Proceedings of the 18th Cologne Workshop on Dope Analysis, Verlag Sport und Buch Strauss, Cologne 2000, pp. 189-196.
7. I. Bellahn, E. Nolteernsting, G. Opfermann, W. Schänzer, in: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (Eds.), Recent Advances in Doping Analysis (6), Proceedings of the 16th Cologne Workshop on Dope Analysis, Verlag Sport und Buch Strauss, Cologne 1998, pp. 489-496.
8. J.A. Van Rhijn, M. O'Keeffe, H.H. Heskamp, S. Collins, J. Chromatogr. A 1995, 712, 67-73.
9. G. Van Vyncht, S. Preece, P. Gaspar, G. Maghuin-Rogister, E. DePauw, J. Chromatogr. A 1996, 750, 43-49.
10. G.A. Jacobson, G.M. Peterson, S. McLean, J. Clin. Pharm. Ther. 1997, 22, 119-126.
11. Y.K. Tan, S.J. Soldin, J. Chromatogr. 1987, 422, 187-195.
12. R. Bergés, J. Segura, X. De La Torre, R. Ventura, J. Chromatogr. B 1999, 723, 173-184.
13. P. Van Eenoo, F.T. Delbeke, Biomed. Chromatogr. 2002, 16, 513-516.
14. R. Rivier, Anal. Chim. Acta 2003, 492, 69-82.
15. A. Polettini, J. Chromatogr. B 1996, 687, 27-42.
16. R. Ventura, L. Damasceno, M. Farré, J. Cardoso, J. Segura, Anal. Chim. Acta. 2000, 418, 79-92.
17. DIN 38 402, Teil 51, Deutsche Einheitsverfahren zur Wasser-, Abwasser- und Schlammuntersuchung, Allgemeine Angaben (Gruppe A), Kalibrierung von Analysenverfahren, Auswertung von Analysenergebnissen und Lineare Kalibrierfunktionen für die Bestimmung von Verfahrenskenngrößen (A 51), Beuth Verlag Berlin, Mai 1986.
18. M.K. Henze, Screening auf β2-Sympatiometika in der Dopinganalytik. Entwicklung und Erprobung eines Gaschromatographisch Massenspektroskopischen Analyseverfahrens für Human-Urin, Shaker Verlag, Aachen, Germany, 2001.
19. I. Seinsch, G. Sigmund, S. Horning, M. Donike, in: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (Eds.), Recent Advances in Doping Analysis (3), Proceedings of the 13th Cologne Workshop on Dope Analysis, Verlag Sport und Buch Strauss, Cologne 1996, pp. 349-355.
20. IOC 1998. Analytical Criteria for Reporting Low Concentrations of Anabolic Steroids. Internal communication to IOC accredited laboratories, Laussane, Switzerland.